LEE001 and Chemoembolization In Patients With Advanced Hepatocellular Carcinoma

NCT02524119 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped This study was terminated after the sponsor withdrew our support

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: LEE011
PROCEDURE: Chemoembolization

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]